Received May 29, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | IM |
dizziness/ light-headed while standing up since 8 days; This non-serious case was reported by a consumer via call center representative and described the occurrence of light headedness in a 79-year-old female patient who received Herpes zoster (Shingrix) solution for injection for prophylaxis. On 18-MAY-2026, the patient received the 2nd dose of Shingrix (intramuscular, unknown arm) .5 ml. On 18-MAY-2026, less than a day after receiving Shingrix, the patient experienced light headedness (Verbatim: dizziness/ light-headed while standing up since 8 days). The outcome of the light headedness was not resolved. It was unknown if the reporter considered the light headedness to be related to Shingrix. Additional Information: GSK Receipt Date: 26-MAY-2026 The batch number was not provided upon follow- up with the reporter.